Naltrexone for treatment of impaired awareness of hypoglycemia in type 1 diabetes: A randomized clinical trial

AIMS: Impaired awareness of hypoglycemia (IAH) is a limiting factor in the treatment of type 1 diabetes (T1D) and is a challenging condition to reverse. The objective of this study was to test the hypothesis that naltrexone therapy in subjects with T1D and IAH will improve counterregulatory hormone...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Diabetes Complications
Main Authors: Moheet, Amir, Mangia, Silvia, Kumar, Anjali, Tesfaye, Nolawit, Eberly, Lynn E, Bai, Yun, Kubisiak, Kristine, Seaquist, Elizabeth R
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4871128/
https://ncbi.nlm.nih.gov/pubmed/26345338
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jdiacomp.2015.08.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados